On March 16th, Beijing time, Siemens Medical successfully listed on the Frankfurt Stock Exchange. The stock price rose by nearly 4% at the beginning of the week, at 29.10 euros ($35.86) per share, and its issue price was 28 euros per share.
It is understood that Siemens Healthcare's IPO issued 150 million shares, accounting for about 15% of the company's common stock, raising 4.2 billion euros (5.2 billion US dollars) (funding will be used for the company's future acquisitions and investments, This enhances the independent value of Siemens Healthcare, which makes its IPO one of the largest IPOs in Germany in the past 20 years and one of the largest IPOs in Europe this year.
At present, the market value of Siemens medical care is about 26 billion to 31 billion euros, lower than the initial forecast of 40 billion euros. According to analysts, the main reason is market volatility and the uncertainty of the company's new product Atellica.
Siemens Medical's listing plan was first launched in 2016 and is part of Siemens's CEO Kezer's efforts to restructure and simplify the company's structure. This will provide investors with a stake in Siemens' business. Opportunities, while providing funding for business expansion. Siemens has said that the promotion of the medical business is a crucial first step, the overall goal is to enable Siemens to acquire start-ups that are developing new medical and diagnostic technologies and services, especially in the United States.
According to Siemens' 2017 financial report, Siemens Medical is one of Siemens' most profitable businesses. In FY2017, Siemens Group's total revenue was 83.049 billion euros and net profit was 6.179 billion euros. Siemens medical revenues reached 13.79 billion euros, with a profit of 2.49 billion euros, accounting for 40% of the total net profit of the Siemens Group, the highest among all businesses. In terms of region, more than half of Siemens Healthcare's revenue growth in FY2017 came from China; in terms of business, its growth was mainly driven by the medical imaging diagnostics business.
According to industry sources, the launch of Siemens Healthcare will enable the healthcare company to invest in research-intensive areas, such as molecular diagnostics, which will allow it to grow faster.
Cotton dry robe poncho, dry robe waterproof, customized logo dry robe, long sleeve dry robe poncho supplier fore more than 7 years. We are factory directly with cheap price.
| Product Name | Cotton Dry Robe Poncho |
| Size | One size or customized |
| Color | Black, Grey, Blue, Red and etc and customized |
| Fabric | Recycled nylon and polyester |
| Sample | Available ( about 5-7 days) |
| Logo | Customized logo accepted |
Cotton Dry Robe Poncho,Dry Robe Waterproof,Customized Logo Dry Robe,Long Sleeve Dry Robe Poncho
Suzhou Golden Gamrnet MFG Co.,Ltd , https://www.svchangerobe.com